Germany Patient Monitoring Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| Historical Data Period | 2019 - 2022 |
| CAGR | 6.40 % |
| Market Concentration | Medium |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Germany Patient Monitoring Market Analysis
The Germany Patient Monitoring Market is expected to witness a CAGR of 6.4% during the forecast period (2022 - 2027).
The COVID-19 pandemic has significantly impacted market growth. The demand for wearable devices and patient monitoring devices has increased during the pandemic period as they allow contactless communication and tracking of medical conditions by clinicians. The spread and early diagnosis of COVID-19 can be determined through the remote monitoring of vital signs such as skin and body temperature, respiratory rate, pulse rate, heart rate, and blood oxygen level, which are related to COVID-19. This is anticipated to have a positive effect on the growth of the studied market. For instance, according to an article published by The Lancet Digital Health Journal, in April 2022, titled "Effectiveness and safety of pulse oximetry in remote patient monitoring of patients with COVID-19: a systematic review", it has been found that pulse oximetry is a practical method for determining whether patients need hospital treatment or may be safely handled at home by remotely monitoring their SpO2 levels. Hence, COVID-19 has impacted the market growth.
Certain factors that are propelling the market growth are the rising burden of chronic diseases due to lifestyle changes and the growing preference for home and patient monitoring.
The increasing prevalence of chronic diseases such as cardiovascular, cancer, diabetes, and neurodegenerative diseases among the population is expected to increase the demand for patient monitoring systems, thereby propelling market growth. For instance, according to GLOBOCAN, in 2020, there were around 628,519 new cancer cases in Germany, with 69,697 new cases of breast cancer, 67,959 prostate cancer, 64,804 lung cancer, 57,528 colorectum cancer, 35,147 bladder cancer, and 333,384 other cancers. Additionally, as stated by the Alzheimer's Association, in the year 2021, more than 1.6 million people in Germany were suffering from Alzheimer's Disease. Thus, the rising burden of chronic diseases is expected to increase the demand for patient monitoring devices such as glucometers, blood pressure machines, and others which are expected to augment the market growth.
Other factors, such as continuous product development and commercialization, and strengthening distribution channels of major product manufacturers are expected to aid the growth of the German patient monitoring market. For instance, in December 2021, Xiaomi launched Redmi Watch 2 Lite smartwatch in the European market, Germany for EUR 79. It supports several features, including tracking blood oxygen levels, steps taken, and heart rate. Also, in April 2020, Withings launched the latest sleep-tracking device, Sleep Analyzer, a mat that can be used to detect sleep apnea. The device analyzes sleep and snoring episodes by using its advanced sensors when placed underneath a mattress.
However, the high cost of technology is expected to hinder market growth over the forecast period.
Germany Patient Monitoring Market Trends
This section covers the major market trends shaping the Germany Patient Monitoring Market according to our research experts:
Remote Patient Monitoring Devices Segment Expects to Register a High CAGR in the Germany Patient Monitoring Market Over the Forecast Period
Remote patient monitoring (RPM) devices allow providers to monitor, report and analyze their patient's acute or chronic conditions from outside the hospital or clinic setting. They enable the practitioner to have a real-time understanding of the patient's disease state and take preventative clinical actions. The remote patient monitoring segment is expected to witness significant growth over the forecast period owing to the factors such as the rising prevalence of chronic diseases such as cardiovascular diseases, diabetes, hypertension, respiratory diseases, neurological diseases, and others, rising adoption of these devices, and growing geriatric population.
The rising burden of chronic diseases among the population and the rising geriatric population is the key factor driving the demand for remote patient monitoring devices. For instance, the high blood sugar caused by diabetes can damage the nerves that control the heart and blood vessels, leading to a variety of cardiovascular diseases like coronary artery disease and stroke, which can narrow the arteries. Also, according to the 2022 statistics published by the United Nations Population Fund, in Germany, a large proportion of the living population is aged 15-64 and accounts for 64% in 2022. In addition, as per the same source, 22% of the population is aged 65 years and above in 2022. Thus, the expected increase in the geriatric population who are more prone to develop chronic diseases is expected to increase the demand for remote patient monitoring devices as well as increase the adoption of these wearable devices due to their easy usage.
Furthermore, the implementation of RPM can improve the management of chronic diseases by measuring critical risk indicators, such as glucose, blood pressure, etc. RPM has various benefits for end-users and hospitals, such as low cost of healthcare, reduction in extended hospitalization, and fewer doctor appointments, among others. This can also help to reduce the cost associated with the treatment of chronic diseases.
Moreover, the rising company activities and product launches in the country are also expected to propel market growth over the forecast period. For instance, in September 2021, Withings launched a new smartwatch, the ScanWatch Horizon, which includes a slew of heart-health monitoring features such as heart rate, ECG, breathing disturbances, blood oxygen levels, sleep, and physical activity tracking. The watch enables the users to identify heart rhythms, as well as the ECG feature to help detect atrial fibrillation.
Thus, owing to the aforementioned factors, the remote patient monitoring segment is expected to grow in Germany over the forecast period.
Germany Patient Monitoring Industry Overview
The Germany patient monitoring market is moderately competitive and consists of several major players. The companies are implementing certain strategic initiatives, such as mergers, new product launches, acquisitions, and partnerships that help in strengthening their market positions. Some of the key players in the market are Abbott Laboratories, GE Healthcare, Boston Scientific Corporation, Johnson & Johnson, Boston Scientific Corporation, Siemens Healthcare GmbH and Koninklijke Philips NV.
Germany Patient Monitoring Market Leaders
Abbott
Johnson & Johnson
Medtronic PLC
Boston Scientific Corporation
GE Healthcare
*Disclaimer: Major Players sorted in no particular order
Germany Patient Monitoring Market News
- In March 2022, Infineon Technologies AG in collaboration with Sleepiz AG launched Infineon XENSIV 60 GHz radar technology, integrated into smart home and healthcare devices, that offers a great opportunity for healthcare applications as they allow to accurately measure vital signs such as heartbeat and breathing rate without touching the body.
- In February 2022, Oppo launched a smartwatch, Oppo Watch Free, in the European market. The fitness tracker can monitor more than 100 sports modes including cricket, skipping, archery, skiing, volleyball, kayaking, and badminton. The fitness tracker can automatically track only four sports - running, walking, rowing (machine), and ellipticals. Additionally, the OPPO Watch Free has a SpO2 sensor, for measuring blood oxygen levels and a heart rate monitor that alerts users when their heart rates are abnormally high or low, sleep tracking, and snoring detection.
Germany Patient Monitoring Market Report - Table of Contents
1. INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Burden of Chronic Diseases due to Lifestyle Changes
4.2.2 Growing Preference for Home and Remote Monitoring
4.3 Market Restraints
4.3.1 High Cost of Technology
4.4 Porter's Five Forces Analysis
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value in USD million)
5.1 By Type of Device
5.1.1 Hemodynamic Monitoring Devices
5.1.2 Neuromonitoring Devices
5.1.3 Cardiac Monitoring Devices
5.1.4 Respiratory Monitoring Devices
5.1.5 Remote Patient Monitoring Devices
5.1.6 Other Types of Devices
5.2 By Application
5.2.1 Cardiology
5.2.2 Neurology
5.2.3 Respiratory
5.2.4 Weight Management and Fitness Monitoring
5.2.5 Other Applications
5.3 By End Users
5.3.1 Home Healthcare
5.3.2 Hospitals and Clinics
5.3.3 Other End Users
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Abbott Laboratories
6.1.2 GE Healthcare
6.1.3 Baxter International Inc.
6.1.4 Becton, Dickinson and Company
6.1.5 Boston Scientific Corporation
6.1.6 Masimo Corporation
6.1.7 Medtronic PLC
6.1.8 Koninklijke Philips NV
6.1.9 Siemens Healthcare GmbH
6.1.10 Johnson & Johnson
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Germany Patient Monitoring Industry Segmentation
As per the scope of this report, patient monitoring devices are monitoring devices that continuously monitor the patient's vital parameters, like blood pressure and heart rates, by using a medical monitor and collecting medical (and other) data from individuals. The Germany Patient Monitoring Market is segmented by Type of Device (Hemodynamic Monitoring Devices, Neuromonitoring Devices, Cardiac Monitoring Devices, Respiratory Monitoring Devices, Remote Patient Monitoring Devices, and Other Types of Devices), Application (Cardiology, Neurology, Respiratory, Weight Management, and Fitness Monitoring, and Other Applications) and End-User (Home Healthcare, Hospitals and Clinics, and Other End Users). The report offers the value (in USD million) for the above segments.
Germany Patient Monitoring Market Research FAQs
What is the current Germany Patient Monitoring Market size?
The Germany Patient Monitoring Market is projected to register a CAGR of 6.40% during the forecast period (2024-2029)
Who are the key players in Germany Patient Monitoring Market?
Abbott, Johnson & Johnson, Medtronic PLC, Boston Scientific Corporation and GE Healthcare are the major companies operating in the Germany Patient Monitoring Market.
What years does this Germany Patient Monitoring Market cover?
The report covers the Germany Patient Monitoring Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Germany Patient Monitoring Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Germany Patient Monitoring Industry Report
Statistics for the 2024 Germany Patient Monitoring market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Germany Patient Monitoring analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
